Sabra Healthcare REIT (NASDAQ:SBRA) Posts Earnings Results, Beats Estimates By $0.02 EPS

Key Points

• Sabra Healthcare REIT reported earnings of $0.38 EPS for the quarter, surpassing analysts' expectations of $0.37 by $0.01.
• Following the earnings release, the company updated its FY 2025 guidance to $1.450-1.470 EPS.
• Scotiabank raised its price target for Sabra Healthcare REIT from $19.00 to $20.00, maintaining a "sector perform" rating on the stock.

Sabra Healthcare REIT (NASDAQ:SBRA - Get Free Report) released its quarterly earnings results on Monday. The real estate investment trust reported $0.38 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.36 by $0.02, Zacks reports. The business had revenue of $189.15 million during the quarter, compared to analyst estimates of $185.64 million. Sabra Healthcare REIT had a return on equity of 6.69% and a net margin of 24.87%. Sabra Healthcare REIT's revenue for the quarter was up 7.4% on a year-over-year basis. During the same quarter in the previous year, the company posted $0.36 earnings per share. Sabra Healthcare REIT updated its FY 2025 guidance to 1.450-1.470 EPS.

Sabra Healthcare REIT Price Performance

Shares of Sabra Healthcare REIT stock traded up $0.08 on Friday, hitting $18.76. 466,351 shares of the company were exchanged, compared to its average volume of 2,430,686. The stock has a market capitalization of $4.50 billion, a price-to-earnings ratio of 24.68, a price-to-earnings-growth ratio of 1.53 and a beta of 0.86. The company has a 50-day moving average price of $18.22 and a 200 day moving average price of $17.54. Sabra Healthcare REIT has a 1-year low of $15.60 and a 1-year high of $20.03. The company has a quick ratio of 4.22, a current ratio of 4.80 and a debt-to-equity ratio of 0.91.

Sabra Healthcare REIT Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, August 29th. Stockholders of record on Friday, August 15th will be issued a dividend of $0.30 per share. This represents a $1.20 annualized dividend and a dividend yield of 6.4%. The ex-dividend date is Friday, August 15th. Sabra Healthcare REIT's payout ratio is currently 157.89%.

Insider Buying and Selling at Sabra Healthcare REIT

In related news, Director Michael J. Foster sold 11,000 shares of the company's stock in a transaction that occurred on Tuesday, May 20th. The stock was sold at an average price of $18.22, for a total value of $200,420.00. Following the transaction, the director directly owned 64,725 shares in the company, valued at approximately $1,179,289.50. This represents a 14.53% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. 1.20% of the stock is currently owned by corporate insiders.

Institutional Inflows and Outflows

A hedge fund recently raised its stake in Sabra Healthcare REIT stock. Focus Partners Wealth boosted its holdings in Sabra Healthcare REIT, Inc. (NASDAQ:SBRA - Free Report) by 11.4% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 23,146 shares of the real estate investment trust's stock after buying an additional 2,375 shares during the quarter. Focus Partners Wealth's holdings in Sabra Healthcare REIT were worth $404,000 at the end of the most recent quarter. 99.40% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

A number of equities analysts have recently weighed in on the company. JMP Securities upped their price objective on Sabra Healthcare REIT from $20.00 to $22.00 and gave the stock a "market outperform" rating in a research note on Wednesday. Scotiabank upped their price objective on Sabra Healthcare REIT from $19.00 to $20.00 and gave the company a "sector perform" rating in a research report on Monday, June 23rd. Three research analysts have rated the stock with a hold rating, three have assigned a buy rating and one has issued a strong buy rating to the company's stock. According to MarketBeat, Sabra Healthcare REIT presently has an average rating of "Moderate Buy" and an average price target of $20.00.

Sabra Healthcare REIT Company Profile

Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.